The partnership will develop differentiated cancer vaccine candidates for certain hematological and solid tumors with high unmet medical needs, according to an April 16 company news release. Both parties will contribute to identifying differentiated cancer antigens based on whole genome sequencing. The most promising vaccine candidates will go through initial phase 1 and 2 studies led by MD Anderson.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
